Helen's Story — Savings from Biosimilar Medicines

Diagnosed in her late twenties with incurable stage four non-Hodgkin lymphoma, Helen, 41, is a wife and mother of two in Florida. She knows she can rely on biosimilars to help when needed and can live her life to the fullest. Biosimilars are medicines that are highly similar to a brand biologic medicines that provide patients with lower-cost, life-changing medicines. Biosimilars treat cancer, rheumatoid arthritis, Crohn’s, and more. Biosimilars are just as safe and effective as brand biologics. Helen’s biosimilar helped to regenerate her white blood cell count, which is a sign of a strong immune system. She is now able to take her family to the beach and amusement parks again, or just go for long nightly walks. Helen shares, “After just two treatments of the biosimilar I started to feel like me again. I was able to go back to work and my most important roles as a mother and wife."

Celebrate a decade of biosimilar savings at https://www.b10similars.org/

Learn more about savings from biosimilars in the AAM 2020 Generic Drug and Biosimilars Access and Savings in the U.S. and Biosimilars Council website.

Sort Order
3

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.